Newsletter | May 11, 2026

05.11.26 -- Feed Media Can Significantly Impact Process Performance

SPONSOR

Webinar: Simplifying ADC Analysis: Real-Time DAR and Concentration Measurement Without Dilution

Unlock faster, safer ADC development with smarter analytics. This Repligen webinar reveals how variable pathlength spectroscopy delivers real-time, accurate DAR and concentration data without dilution. Explore case studies showing reduced variability, minimized handling of potent payloads, and streamlined workflows. Learn how PAT-driven insights enhance process control, accelerate scale-up, and replace traditional UV-Vis methods for more consistent, efficient manufacturing outcomes. Click here to learn more.

FOCUS ON UPSTREAM MANUFACTURING

Feed Media Can Significantly Impact Process Performance

In this segment from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration,” our panelists respond to an audience question about feed media and its impact on process performance.

Achieving A 9-Month Timeline Through Integrated Cell Line Development

Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.

Scalable Strategies For Intensified Viral Vector Production In Cell Culture

Learn a strategy for scalable bioprocessing and media optimization that drives intensified viral vector production. Achieve high cell density, excellent viability, and consistent AAV titers from 50mL to 5L.

A Cell Line Development Platform Accelerating Timelines To Clinic

To support a seamless transition from early clinical studies through to commercial manufacturing, cell line expression systems must be carefully designed and selected based on several critical attributes.

Optimizing Bispecific Antibody Expression Via Multi-Omics Analysis

Discover how diagnosing ribosome pausing sites and optimizing codon usage dramatically improves bispecific antibody titers, turning difficult-to-express candidates into viable therapeutics.

How Post-Translational Control Enables Next-Generation Biologics

In Vitro Glycoengineering (IVGE) precisely controls glycosylation to optimize biopharma workflows, serving as a critical platform for advancing key therapeutic areas in today's industry.

The Proven, Practical Gateway To Upstream Process Intensification

N-1 perfusion enables higher inoculum densities, faster production, and reduced costs without altering fed-batch processes. Explore a practical path to intensification for biologics manufacturers.

Media Exchange In iPSC Cell Expansion And Differentiation

Low-shear, closed-system media exchange in iPSC differentiation is vital for scalability. This study compares automated centrifugation to gravity sedimentation, showing equivalent or superior outcomes.

Optimizing Upstream High-Throughput Biologics Development

Gain insight into designing large Design-of-Experiment (DOE) upstream process development studies and the elements that could positively or negatively affect your throughput.

From Seaweed To Scale-Up: IBioIC's Journey With Fermentation Technology

The circular bioeconomy requires bioprocess scale-up capabilities. Access to flexible, user-friendly pilot-scale equipment is vital for companies to move from lab-bench innovation to commercial reality.

Top 5 Barriers To Scalable ncAA Conjugation And What's Finally Changing

Examine data from an anti-GPCR VHH program that shows how ncAA conjugation barriers, like yield loss, toxicity, incomplete incorporation, can be overcome at scale.

Controlled Production Of MSC-Derived EVs In Stirred-Tank Bioreactors

See how stirred-tank bioreactors overcome the scalability limitations of static culture for MSC-EV production, while Raman spectroscopy provides unprecedented real-time quality monitoring.

Unlocking The Potential Of Electroporation

Electroporation enables genetic research by introducing material into cells, advancing disease modeling, gene therapy, and ion channel studies.

UPSTREAM MANUFACTURING SOLUTIONS

Integrated Reagent Solutions For CAR-T/NK Development And Manufacturing - ACROBiosystems

Innovating Upstream AAV Manufacturing For The Next Wave Of Gene Therapies - Mirus Bio

Enable Your Perfusion Process And Maximize Productivity - FUJIFILM Biosciences

The Future Of Media And Buffer Manufacturing - Nucleus Biologics

SPONSOR

Webinar: Advancing Next Gen Antibodies and ADCs: From AI Driven Cell Line Development to Integrated Manufacturing

Explore how AI-driven cell line development and integrated CMC strategies are transforming next-generation ADC manufacturing. This Cytiva webinar covers faster clone selection, improved productivity, scale-up considerations, and future-ready bioprocessing approaches for complex antibody therapeutics. Gain insights into emerging technologies that support consistency, accelerate timelines, and strengthen commercialization readiness across evolving antibody-based therapies. Click here to learn more.

Connect With Bioprocess Online: